(2R,3R,4R,5S)-6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-HEXANE-1,2,3,4,5-PENTAOL
Compound with spectra: 1 NMR
![(2R,3R,4R,5S)-6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-HEXANE-1,2,3,4,5-PENTAOL](/api/compound/7C2gbtUSNN0.png?ph=true&h=300&w=458 "(2R,3R,4R,5S)-6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-HEXANE-1,2,3,4,5-PENTAOL")
| SpectraBase Compound ID | 7C2gbtUSNN0 |
|---|---|
| InChI | InChI=1S/C32H29N5O5/c38-17-28(40)31(42)30(41)27(39)16-34-36-32-23(24-15-33-25-12-6-5-11-22(24)25)14-26(35-37-32)29-20-9-3-1-7-18(20)13-19-8-2-4-10-21(19)29/h1-16,27-28,30-31,33,38-42H,17H2,(H,36,37)/b34-16+/t27-,28-,30+,31-/m1/s1 |
| InChIKey | PNCFYFFGCZFYLH-JJFJNNTDSA-N |
| Mol Weight | 563.6 g/mol |
| Molecular Formula | C32H29N5O5 |
| Exact Mass | 563.216869 g/mol |
| Enantiomer InChIKey | PNCFYFFGCZFYLH-BNYINVEBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2R,3S,4S)-5-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-PENTANE-1,2,3,4-TETRAOL
4-[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YLAMINO]-BENZENESULFONIC-ACID
3-(Bis(1-benzyl-1H-indol-3-yl)methyl)-2-butoxyquinoline
Pyridine, 2,2'-(5,13-pentaphenediyl)bis-
1-Acetyl-3-(2-benzyloxyphenyl)-4,6-dimethoxyindole
3-tert-Butoxycarbonyl-2,2,dimethyl-4-[2-(2-furyl)quinolin-4-yl]oxazolidine
5-carbomethoxy-3,4-bis(1H-indol-3-yl)-1H-pyrrole-2-carboxylic acid
pyrano[2,3-c]pyrazole-5-carbonitrile, 6-amino-2,4-dihydro-4-(5-methyl-2-thienyl)-3-phenyl-
BENZYL-2-ALPHA-O-METHYL-4-O-CAPRILOYL-5-N-ACETYL-8,9-O-ISOPROPYLIDENE-NEURAMINATE
| Title | Journal or Book | Year |
|---|---|---|
| An Efficient Synthesis and Reactions of Novel Indol-ylpyridazinone Derivatives with Expected Biological Activity | Molecules | 2007 |